In vitro uptake of methyl tert-butyl ether in male rat kidney: Use of a two-compartment model to describe protein interactions

Toxicology and Applied Pharmacology

Volumn 145, Issue 2, 1997, Pages 340-348

  Poet, Torka S ^a   Borghoff, Susan J ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 GLOBULIN; TERT BUTYL METHYL ETHER;

ANIMAL TISSUE; ARTICLE; COMPARTMENT MODEL; FEMALE; KIDNEY TUBULE ABSORPTION; MALE; NONHUMAN; PARTITION COEFFICIENT; PROTEIN BINDING; RAT; TISSUE DISTRIBUTION; TOXICOKINETICS;

ANIMALIA;

EID: 0031213606     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8193     Document Type: Article

References (28)

1. Alison R. H., Capen C. C., Prentice D. E. Neoplastic lesions of questionable significance to humans. Toxicol. Pathol. 22:1994;179-185.
2. Borghoff S. J., Jayjock E., Murphy J. E. Methylterttert. Toxicologist. 30:1995;34.
3. Borghoff S. J., Largarde W. H. Assessment of binding of 2,4,4-trimethyl-2-pentanol to low-molecular-weight proteins isolated from kidneys of male rats and humans. Toxicol. Appl. Pharmacol. 119:1993;228-235.
4. Borghoff S. J., Miller A. B., Bowen J. P., Swenberg J. A. Characteristics of chemical binding to α2u-globulinin vitro. Toxicol. Appl. Pharmacol. 107:1991;228-238.
5. Borghoff S. J., Murphy J. E., Medinsky M. A. Development of a physiologically based pharmacokinetic model for methyltertiarytertiary. Fundam. Appl. Toxicol. 30:1996;264-275.
6. Borghoff S. J., Short B. G., Swenberg J. A. Biochemical mechanisms and pathobiology of α2u-globulin nephropathy. Ann. Rev. Pharmacol. Toxicol. 30:1990;349-367.
7. Borghoff S. J., Youtsey N. L., Swenberg J. A. Comparison of European high test gasoline and PS-6 unleaded gasoline in their abilities to induce a2u-globulin nephropathy and renal cell proliferation. Toxicol. Lett. 63:1992;21-33.
8. Charbonneau M., Strasser J. J., Turner M. J., Swenberg J. A. Involvement of reversible binding to α2u-globulin in 1,4-dichlorobenzene-induced nephrotoxicity. Toxicol. Appl. Pharmacol. 99:1989;122-132.
9. J. S. Chun, W. J. Kintigh, 1993, Methyl tertiary-butyl ether: Twenty-eight day vapor inhalation study in rats and mice, Bushy Run Research Center, Export, PA.
10. Cinelli S., Ciliutti P., Falezza A., Meli C., Caserta L., Marchetti S., Seeberg A. H., Vericat J. A. Absence of mutagenicity of methyl-tertiary-butyl ether. Toxicol. Lett. Suppl. 1:1992;300.
11. CRC, 1995, CRC Handbook of Chemistry and Physics, 6, 89, CRC Press, Boca Raton, FL.
12. Dunnick J. K., Eustis S. L., Haseman J. K. Development of kidney tumors in the male F344/N rat after treatment with dimethyl methylphosphonate. Fundam. Appl. Toxicol. 11:1988;91-99.
13. B. Fichtl, A. v. Nieciecki, K. Walter, 1991, Tissue binding versus plasma binding of drugs: General principles and pharmacokinetic consequences, Advances in Drug Research, B. Testa, 117, 166, Academic Press, New York.
14. Gargas M. L., Burgess R. J., Voisard R. J., Cason G. H., Andersen M. E. Partition coefficients of low-molecular-weight volatile chemicals in various liquid tissues. Toxicol. Appl. Pharmacol. 98:1989;87-99.
15. Kim C., Manning R. O., Brown R. P., Bruckner J. V. Use of the vial equilibration technique for determination of metabolic rate constants for dichloromethane. Toxicol. Appl. Pharmacol. 139:1996;243-251.
16. Kirschner E. M. Growth of top 50 chemicals slowed in 1995 from very high 1994 rate. Chem. Eng. News. April 8:1996;16-22.
17. Kurtz D. T., Feigelson P. Multihormonal induction of hepatic α2u-globulin mRNA as measured by hybridization to complementary DNA. Proc. Natl. Acad. Sci. USA. 74:1977;4791-4795.
18. Lehman-McKeeman L. D., Caudill D. d. Fundam. Appl. Toxicol. 23:1994;562-568.
19. 2u. Toxicol. Appl. Pharmacol. 99:1989;250-259.
20. MacFarland H. N., Ulrich C. E., Holdsworth C. E., Kitchen D. N., Halliwell W. H., Blum S. C. A chronic inhalation study with unleaded gasoline vapor. J. Am. Coll. Toxicol. 3:1984;231-248.
21. Olson M. J., Johnson J. T., Reidy C. A. A comparison of male rat and human urinary proteins: Implications for human resistance to hyaline droplet nephropathy. Toxicol. Appl. Pharmacol. 102:1990;524-536.
22. Prescott-Mathews J. S., Wolf D. C., Wong B. A., Borghoff S. J. Methyltert. Toxicol. Appl. Pharmacol. 143:1997;301-314.
23. Robinson M., Bruner R. H., Olson G. R. Fourteen- and ninety-day oral toxicity studies of methyl tertiary-butyl ether in Sprague-Dawley rats. J. Am. Coll. Toxicol. 9:1990;525-540.
24. Rodgers I. S., Baetche K. P. Interpretation of male rat renal tubule tumors. Environ. Health Perspect. 101:1993;45-52.
25. Sato A., Nakajima T. A vial equilibration method to evaluate the drug-metabolizing enzyme activity for volatile hydrocarbons. Toxicol. Appl. Pharmacol. 47:1979;41-46.
26. 2u-Globulin nephropathy: Review of the cellular and molecular mechanisms involved and their implications for human risk assessment. Environ. Health Perspect. 101:1993;39-44.
27. 2u. Toxicol. Appl. Pharmacol. 97:1989;35-46.
28. Alpha 2u globulin: Association with chemically induced renal toxicity and neoplasia in the male rat. 1991;Center for Environmental Research Information, Cincinnati.